Advertisement

APBI Intraoperative Technique with Electrons

  • Roberto Orecchia
  • Giovanni B. Ivaldi
  • Maria C. Leonardi
Chapter

The rationale for the irradiation of a limited volume of tissue around the surgical bed in place of whole breast irradiation comes from numerous studies that have shown that 80% or more of local relapses after conservative surgery and radiation therapy occur at the original tumor site. Particularly in low-risk patients, a more limited local treatment could be justified. Intraoperative radiotherapy with electrons (IOERT) has the advantages of reducing the radiotherapy course from 5–7 weeks to a single dose given directly in the operating room immediately following tumor resection, and of reducing the course of external radiation treatment needed when IOERT is used as boost. This would overcome some of the constraints that may prevent patients (especially older patients) from having breast-conserving therapy, such as accessibility to a radiotherapy center and the effects of a prolonged treatment course on the patient's social life and financial resources. Moreover, IOERT could minimize some of the potential side effects associated with conventional EBRT because the skin and subcutaneous tissues are not irradiated and the irradiated volumes of lung and heart are significantly reduced. IOERT thus lends itself to implementing the treatment philosophy of partial breast irradiation, but results from the ELIOT randomized Phase III trial are awaited before considering its use as a standard treatment.

Keywords

Breast Cancer Sentinel Node Biopsy Radiat Oncol Biol Phys Early Stage Breast Cancer Radiation Therapy Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abner AL, Connolly JL, Recht A, et al. (2000) The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infi ltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88:1072–77PubMedCrossRefGoogle Scholar
  2. Arthur D (2003) Accelerated partial breast irradiation: a change in treatment paradigm for early stage breast cancer. J Surg Oncol 84:185–91PubMedCrossRefGoogle Scholar
  3. Arthur DW, Koo D, Zwicker RD, et al. (2003) Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 56:681–9PubMedGoogle Scholar
  4. Athas WF, Adams-Cameron M, Hunt WC, et al. (2000) Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92:269–71PubMedCrossRefGoogle Scholar
  5. Baglan KL, Martinez AA, Frazier RC, et al. (2001) The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 50:1003–11PubMedCrossRefGoogle Scholar
  6. Bartelink H, Horiot JC, Poortmans P, et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378–87PubMedCrossRefGoogle Scholar
  7. Bartelink H, Horiot JC, Poortmans PM, et al. (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol 25 (22):3259–65PubMedCrossRefGoogle Scholar
  8. Belkacemi Y, Chauvet MP, Giard S, et al. (2003) Partial breast irradiation: high dose rate peropera-tive brachytherapy technique using the MammoSite. Cancer Radiother 7 Suppl 1:129s–36sPubMedGoogle Scholar
  9. Bovi J, Qi XS, White J, Li XA, et al. (2007) Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. Radiother Oncol 84(3):226–32PubMedCrossRefGoogle Scholar
  10. Calvo FA, Meirino RM, Orecchia R (2006) Intraoperative radiation therapy. Part 2. Clinical results. Crit Rev Oncol Hematol 59:116–27PubMedCrossRefGoogle Scholar
  11. Chen PY, Vicini FA, Benitez P, et al. (2006) Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106:991–9PubMedCrossRefGoogle Scholar
  12. Ciocca M, Piazzi V, Lazzari R, et al. (2006) Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol 78(2):213–6PubMedCrossRefGoogle Scholar
  13. Clarke M, Collins R, Darby S, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–106PubMedGoogle Scholar
  14. Du X, Freeman JL, Freeman DH, et al. (1999) Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early stage breast cancer from 1983 to 1985. J Gerontol A Biol Sci Med Sci 54:474–78Google Scholar
  15. Dubois JB, Hay M, Gely S, et al. (1997) IORT in breast carcinomas. Front Radiat Ther Oncol 31:131–137PubMedCrossRefGoogle Scholar
  16. Elkinol MM, Sutton H (1959) X-ray damage and recovery in mammalian cells in culture. Nature 184:1293CrossRefGoogle Scholar
  17. Formenti SC (2005) External-beam partial-breast irradiation. Semin Radiat Oncol 15:92–9PubMedCrossRefGoogle Scholar
  18. Formenti SC, Truong MT, Goldberg JD, et al. (2004) Prone accelerated partial breast radiation (p-APBI) after breast conserving surgery; preliminary clinical results and dose volume histogram (DVH) analysis. Int J Radiat Onc Biol Phys 60:493–504CrossRefGoogle Scholar
  19. Fischer B, Jeong JH, Anderson S, et al. (2002) Twenty-fi ve-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and radiation. N Engl J Med 8:567–75CrossRefGoogle Scholar
  20. Fischer B, Anderson S, Redmond CK, et al. (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456–61CrossRefGoogle Scholar
  21. Harpe JL, Jenrette JM, Vanek KN, et al. (2005) Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 61:169–74Google Scholar
  22. Holland R, Veling SH, Mravunac M, et al. (1985) Histologic multifocality of Tis, TI-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979–90PubMedCrossRefGoogle Scholar
  23. Holmes DR, Baum M, Joseph D (2007) The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg 194:507–510PubMedCrossRefGoogle Scholar
  24. Intra M, Gatti G, Luini A, et al. (2002) Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg 137(6):737–40PubMedCrossRefGoogle Scholar
  25. Intra M, Luini A, Gatti G, et al. (2006) Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery 140(3):467–71PubMedCrossRefGoogle Scholar
  26. Ivaldi GB, Leonardi MC, Orecchia R, et al. (2008) Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys 72(2):485–93PubMedGoogle Scholar
  27. Keisch M, Vicini F, Kuske RR, et al. (2003) Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55(2):289–93PubMedGoogle Scholar
  28. King TA, Bolton JS, Kuske RR, et al. (2000) Long-term results of e-fi eld brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180:299–304PubMedCrossRefGoogle Scholar
  29. Kozak KR, Smith BL, Adams J, et al. (2006) Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 66:691–8PubMedGoogle Scholar
  30. Kuske RR, Winter K, Arthur DW (2004) A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer; initial outcomes of RTOG 9517. Proc Am Soc Clin Oncol 23:18Google Scholar
  31. Lea DE (1955) Actions of radiation on living cells. Cambridge University Press, CambridgeGoogle Scholar
  32. Lemanski C, Azria D, Thezenas S, et al. (2006) Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. Int J Radiat Oncol Biol Phys 64(5):1410–1415PubMedGoogle Scholar
  33. Luini A, Orecchia R, Gatti G, et al. (2005) The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat 93:55–9PubMedCrossRefGoogle Scholar
  34. Merrick HW III, Battle JA, Padgett BJ, et al. (1997) IORT for early breast cancer: a report on long-term results. Front Radiat Ther Oncol 31:126–30PubMedCrossRefGoogle Scholar
  35. Meurk ML, Goer DA, Spalek G, et al. (1997) The Mobetron: a new concept for IORT. Front Radiat Ther Oncol 31:65–70PubMedCrossRefGoogle Scholar
  36. Mussari S, Sabino Della Sala W, Busana L, et al. (2006a) Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 182 (10):589–95Google Scholar
  37. Mussari S, Sabino Della Sala W, et al. (2006b) Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 182(10):589–95Google Scholar
  38. NSABP B-39, RTOG 0413 (2006) A randomized Phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol 4:719–21Google Scholar
  39. Ollila DW, Klauber-DeMore N, Tesche LJ, et al. (2007) Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol 14(2): 660–9PubMedCrossRefGoogle Scholar
  40. Orecchia R, Ciocca M, Lazzari R, et al. (2003) Intraoperative radiation therapy with electrons (ELIOT) in early stage breast cancer. Breast 12:483–90PubMedCrossRefGoogle Scholar
  41. Orecchia R, Ciocca M, Tosi G, et al. (2005) Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance program. Breast 14:541–6PubMedCrossRefGoogle Scholar
  42. Ott OJ, Hildebrandt G, Potter R, et al. (2007) Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German—Austrian multi-centre trial. Radiother Oncol 82:281–6PubMedCrossRefGoogle Scholar
  43. Patel RR, Das RK (2006) Image-guided breast brachytherapy: an alternative to whole-breast radiotherapy. Lancet Oncol 7:407–15PubMedCrossRefGoogle Scholar
  44. Perez CA, Brady LW (2008) Principles and practice of radiation oncology. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  45. Petit JY, Veronesi U, Luini A, et al. (2005) When mastectomy becomes inevitable: the nipple-sparing approach. Breast 14(6):527–31PubMedCrossRefGoogle Scholar
  46. Petit JY, Veronesi U, Orecchia R, et al. (2006) Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Breast Cancer Res Treat 96(1):47–51PubMedCrossRefGoogle Scholar
  47. Petit JY, Veronesi U, Rey P, et al. (2009) Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases. Breast Cancer Res Treat 114(1):97–101PubMedCrossRefGoogle Scholar
  48. Polgár C, Sulyok Z, Fodor J, et al. (2002) Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: fi ve-year results of a phase I–II study and initial fi ndings of a randomized phase III trial. J Surg Oncol 80:121–8PubMedCrossRefGoogle Scholar
  49. Polgár C, Major T, Fodor J, et al. (2004) High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60:1173–81PubMedGoogle Scholar
  50. Polgár C, Strnad V, Major T (2005) Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 15:116–22PubMedCrossRefGoogle Scholar
  51. Polgár C, Lovey K, Major T, et al. (2006) Partial breast irradiation (PBI) versus whole breast irradiation (WBI) after breast conserving surgery for low risk breast cancer patients: 5-year results of a randomized study. Radiother Oncol 81:S148Google Scholar
  52. Poortmans P, Bartelink H, Horiot J, et al. (2004) The infl uence of the boost technique on local control in breast conserving treatment in the EORTC “boost versus no boost” randomized trial. Radiother Oncol 72:25–33PubMedCrossRefGoogle Scholar
  53. Read J (1952) The effect of ionizing radiation on broad beam root. Br J Radiol 25:89–154PubMedCrossRefGoogle Scholar
  54. Reitsamer R, Sedlmayer F, Kopp M, et al. (2006) The Salzburg concept of intraoperative radiotherapy for breast cancer: results and considerations. Int J Cancer 118:2882–7PubMedCrossRefGoogle Scholar
  55. Ribeiro GG, Magee B, Swindell R, et al. (1993) The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 5:278–83CrossRefGoogle Scholar
  56. Sanders ME, Scroggins T, Ampil FL, et al. (2007) Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 25:996–1002PubMedCrossRefGoogle Scholar
  57. Thames HD, Withers HR, Peters CJ, et al. (1982) Changes in early and late radiation responses with altered dose fractionation. Implications for dose—survival relationships. Int J Radiat Oncol Biol Phys 8:219PubMedGoogle Scholar
  58. Vaidya JS, Tobias JS, Baum M, et al. (2004) Intraoperative radiotherapy for breast cancer. Lancet Oncol 5:165–73PubMedCrossRefGoogle Scholar
  59. Vaidya JS, Tobias JS, Baum M, et al. (2005) Targeted intraoperative radiotherapy (TARGIT): an innovative approach to partial breast irradiation. Semin Radiat Oncol 15:84–91PubMedCrossRefGoogle Scholar
  60. Vaidya JS, Baum M, Tobias JS, et al. (2006) Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Radiat Oncol Biol Phys 66(5):1335–8PubMedGoogle Scholar
  61. Veronesi U, Luini A, Del Vecchio M, et al. (1993) Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Eng J Med 328:1587–91CrossRefGoogle Scholar
  62. Veronesi U, Marubini E, Mariani L, et al. (2001a) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12:997–1003CrossRefGoogle Scholar
  63. Veronesi U, Orecchia R, Luini A, et al. (2001b) A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37(17):2178–83CrossRefGoogle Scholar
  64. Veronesi U, Cascinelli N, Mariani L, et al. (2002) Twenty-year follow-up of a surgery with radical mastectomy for early breast cancer. N Engl J Med 16:1227–32CrossRefGoogle Scholar
  65. Veronesi U, Gatti G, Luini A, et al. (2003a) Full-dose intraoperative radiotherapy with electrons during breast conserving surgery. Arch Surg 138:1253–6CrossRefGoogle Scholar
  66. Veronesi U, Gatti G, Luini A, et al. (2003b) Intraoperatrive radiation therapy for breast cancer: technical notes. The Breast J 9 (2):106–112CrossRefGoogle Scholar
  67. Veronesi U, Orecchia R, Luini A, et al. (2008) Full dose intraoperative radiotherapy with electrons (ELIOT) during breast conserving surgery: experience with 1246 cases. ecancermedicalscience 2:65Google Scholar
  68. Vicini FA, Kestin LL, Edmunson GK, et al. (1999) Dose—volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 45:803–10PubMedGoogle Scholar
  69. Vicini FA, Kestin L, Chen P, et al. (2003) Limited-fi eld radiation therapy in the management of early stage breast cancer. J Natl Cancer Inst 95:1205–10PubMedCrossRefGoogle Scholar
  70. Vicini F, Winter K, Straube W, et al. (2005) A phase I/II trial to evaluate three-dimensional confor-mal radiation therapy confi ned to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys 63:1531–7PubMedCrossRefGoogle Scholar
  71. Voogd AC, Peterse JL, Crommelin MA, et al. (1999) Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Eur J Cancer 35:1828–37PubMedCrossRefGoogle Scholar
  72. Walner P, Arthur D, Bartelink H, et al. (2004) Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda. J Natl Cancer Inst 96:175–84Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Roberto Orecchia
    • 1
  • Giovanni B. Ivaldi
    • 1
  • Maria C. Leonardi
    • 1
  1. 1.Department of Radiation OncologyEuropean Institute of OncologyMilanItaly

Personalised recommendations

Cite chapter

Buy options